Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory J Dore

Showing results (341-350 of 404) with videos related to

Pageof 41
Sort By:
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|January 18, 2019
A systematic, deep sequencing-based methodology for identification of mixed-genotype hepatitis C virus infectionsAndrea D Olmstead, Vincent Montoya, Celia K Chui, et al.
Virology|July 27, 2010
HBV mutations in untreated HIV-HBV co-infection using genomic length sequencingJennifer Audsley, Margaret Littlejohn, Lilly Yuen, et al.
BMC Infectious Diseases|November 18, 2025
A point-of-care testing intervention to improve hepatitis C diagnosis and treatment uptake among people attending Aboriginal community controlled health services: the SCALE-C studySamira Hosseini-Hooshyar, Heather Valerio, Erin Flynn, et al.
The International Journal on Drug Policy|August 4, 2025
Patient preferences for simplified hepatitis C testing modalities among people at risk of hepatitis C infection in Australia: the SELECT studyAnnabelle Stevens, Jake Abbott, Loriate Gribbin, et al.
The Lancet. Gastroenterology & Hepatology|February 17, 2024
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictionsAlison D Marshall, Alex R Willing, Abe Kairouz, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|March 12, 2019
Genomic characterization of hepatitis C virus transmitted founder variants with deep sequencingArunasingam Abayasingam, Preston Leung, Auda Eltahla, et al.
The Journal of Infectious Diseases|March 14, 2018
Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care AssayFrancois M J Lamoury, Sahar Bajis, Behzad Hajarizadeh, et al.
Journal of Hepatology|January 22, 2017
NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcomeStefan Zeuzem, Masashi Mizokami, Stephen Pianko, et al.
Journal of Virology|May 22, 2009
Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfectionJ Judy Chang, Sunee Sirivichayakul, Anchalee Avihingsanon, et al.
Journal of Hepatology|May 23, 2021
Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infectionGail V Matthews, Sanjay Bhagani, Marc Van der Valk, et al.
Pageof 41

Showing results (341-350 of 404) with videos related to

Sort By:
Pageof 41
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|January 18, 2019
A systematic, deep sequencing-based methodology for identification of mixed-genotype hepatitis C virus infectionsAndrea D Olmstead, Vincent Montoya, Celia K Chui, et al.
Virology|July 27, 2010
HBV mutations in untreated HIV-HBV co-infection using genomic length sequencingJennifer Audsley, Margaret Littlejohn, Lilly Yuen, et al.
BMC Infectious Diseases|November 18, 2025
A point-of-care testing intervention to improve hepatitis C diagnosis and treatment uptake among people attending Aboriginal community controlled health services: the SCALE-C studySamira Hosseini-Hooshyar, Heather Valerio, Erin Flynn, et al.
The International Journal on Drug Policy|August 4, 2025
Patient preferences for simplified hepatitis C testing modalities among people at risk of hepatitis C infection in Australia: the SELECT studyAnnabelle Stevens, Jake Abbott, Loriate Gribbin, et al.
The Lancet. Gastroenterology & Hepatology|February 17, 2024
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictionsAlison D Marshall, Alex R Willing, Abe Kairouz, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|March 12, 2019
Genomic characterization of hepatitis C virus transmitted founder variants with deep sequencingArunasingam Abayasingam, Preston Leung, Auda Eltahla, et al.
The Journal of Infectious Diseases|March 14, 2018
Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care AssayFrancois M J Lamoury, Sahar Bajis, Behzad Hajarizadeh, et al.
Journal of Hepatology|January 22, 2017
NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcomeStefan Zeuzem, Masashi Mizokami, Stephen Pianko, et al.
Journal of Virology|May 22, 2009
Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfectionJ Judy Chang, Sunee Sirivichayakul, Anchalee Avihingsanon, et al.
Journal of Hepatology|May 23, 2021
Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infectionGail V Matthews, Sanjay Bhagani, Marc Van der Valk, et al.
Pageof 41